Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Holst

Showing results (251-260 of 1,570) with videos related to

Pageof 157
Sort By:
Pancreas|January 12, 2000
Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitisC Hedetoft, S P Sheikh, S Larsen, et al.
Acta Physiologica Scandinavica|January 1, 1979
Nervous control of pancreatic exocrine secretion in pigsJ J Holst, O B Schaffalitzky de Muckadell, J Fahrenkrug
Metabolism: Clinical and Experimental|March 1, 1986
The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose-induced thermogenesis in manA Astrup, J Madsen, J J Holst, et al.
Diabetologia|November 1, 1983
Circulating glucagon after total pancreatectomy in manJ J Holst, J H Pedersen, F Baldissera, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosaJ J Holst, S Aggestrup, F B Loud, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1996
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resectionsM A Nauck, J Siemsglüss, C Orskov, et al.
Pancreas|September 1, 1990
Somatostatin inhibits neurally stimulated pancreatic secretion indirectlyJ J Holst, O B Schaffalitzky de Muckadell, J Fahrenkrug
Diabetologia|July 1, 1990
Porcine pancreastatin has no effect on endocrine secretion from the pig pancreasJ J Holst, C G Ostenson, H Harling, et al.
Expert Opinion on Investigational Drugs|March 12, 2011
Lixisenatide for type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Tina Vilsbøll, et al.
Journal of Applied Physiology|June 1, 1976
Glucagon and plasma catecholamines during beta-receptor blockade in exercising manH Galbo, J J Holst, N J Christensen, et al.
Pageof 157

Showing results (251-260 of 1,570) with videos related to

Sort By:
Pageof 157
Pancreas|January 12, 2000
Effect of glucagon-like peptide 1(7-36)amide in insulin-treated patients with diabetes mellitus secondary to chronic pancreatitisC Hedetoft, S P Sheikh, S Larsen, et al.
Acta Physiologica Scandinavica|January 1, 1979
Nervous control of pancreatic exocrine secretion in pigsJ J Holst, O B Schaffalitzky de Muckadell, J Fahrenkrug
Metabolism: Clinical and Experimental|March 1, 1986
The effect of chronic ephedrine treatment on substrate utilization, the sympathoadrenal activity, and energy expenditure during glucose-induced thermogenesis in manA Astrup, J Madsen, J J Holst, et al.
Diabetologia|November 1, 1983
Circulating glucagon after total pancreatectomy in manJ J Holst, J H Pedersen, F Baldissera, et al.
The Journal of Clinical Endocrinology and Metabolism|April 1, 1983
Content and gel filtration profiles of glucagon-like and somatostatin-like immunoreactivity in human fundic mucosaJ J Holst, S Aggestrup, F B Loud, et al.
Zeitschrift Fur Gastroenterologie|March 1, 1996
Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resectionsM A Nauck, J Siemsglüss, C Orskov, et al.
Pancreas|September 1, 1990
Somatostatin inhibits neurally stimulated pancreatic secretion indirectlyJ J Holst, O B Schaffalitzky de Muckadell, J Fahrenkrug
Diabetologia|July 1, 1990
Porcine pancreastatin has no effect on endocrine secretion from the pig pancreasJ J Holst, C G Ostenson, H Harling, et al.
Expert Opinion on Investigational Drugs|March 12, 2011
Lixisenatide for type 2 diabetes mellitusMikkel Christensen, Filip K Knop, Tina Vilsbøll, et al.
Journal of Applied Physiology|June 1, 1976
Glucagon and plasma catecholamines during beta-receptor blockade in exercising manH Galbo, J J Holst, N J Christensen, et al.
Pageof 157